Evidence map›Paper›PMID 28330163›Full record

Article3 Biotech2016

Probing an optimal class distribution for enhancing prediction and feature characterization of plant virus-encoded RNA-silencing suppressors.

Abhigyan Nath, Karthikeyan Subbiah

Abstract read
In one paragraph

Article in 3 Biotech, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Abhigyan NathDepartment of Computer Science, Banaras Hindu University, Varanasi, India. abhigyannath01@gmail.com.
Karthikeyan SubbiahDepartment of Computer Science, Banaras Hindu University, Varanasi, India. karthinikita@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To counter the host RNA silencing defense mechanism, many plant viruses encode RNA silencing suppressor proteins. These groups of proteins share very low sequence and structural similarities among them, which consequently hamper their annotation using sequence similarity-based search methods. Alternatively the machine learning-based methods can become a suitable choice, but the optimal performance through machine learning-based methods is being affected by various factors such as class imbalance, incomplete learning, selection of inappropriate features, etc. In this paper, we have proposed a novel approach to deal with the class imbalance problem by finding the optimal class distribution for enhancing the prediction accuracy for the RNA silencing suppressors. The optimal class distribution was obtained using different resampling techniques with varying degrees of class distribution starting from natural distribution to ideal distribution, i.e., equal distribution. The experimental results support the fact that optimal class distribution plays an important role to achieve near perfect learning. The best prediction results are obtained with Sequential Minimal Optimization (SMO) learning algorithm. We could achieve a sensitivity of 98.5 %, specificity of 92.6 % with an overall accuracy of 95.3 % on a tenfold cross validation and is further validated using leave one out cross validation test. It was also observed that the machine learning models trained on oversampled training sets using synthetic minority oversampling technique (SMOTE) have relatively performed better than on both randomly undersampled and imbalanced training data sets. Further, we have characterized the important discriminatory sequence features of RNA-silencing suppressors which distinguish these groups of proteins from other protein families.

Indexed as

Balanced training setClass imbalance problemOptimal class distributionRandom undersamplingRelieffRNA silencingSMOTESVM

Identifiers

PMID28330163
PMCPMC4801844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.